Continuous Assessment of Hemodynamic Compensation in Pediatric Trauma Patients

Launched by UNIVERSITY OF COLORADO, DENVER · May 27, 2021

Keywords

ClinConnect Summary

This clinical trial is studying how well pediatric trauma patients are able to maintain their blood circulation and vital signs after an injury. Researchers will use a special device called the Flashback CRI T1 tablet to collect information on these patients' health for 12 to 24 hours after their trauma. The device works by using a small sensor placed on the finger to read important data. It's important to note that this study is observational, meaning that it will not influence treatment decisions, and doctors will not use the data to make immediate health choices.

To be eligible for the study, children between 31 days and 26 years old who experience a serious trauma at designated hospitals can participate. However, pregnant patients, those in jail, and patients who do not wish to take part in the study at any time will not be included. Participants can expect to have their health monitored closely during their hospital stay, and researchers will later review the collected data to find patterns that might help understand how trauma impacts blood loss and the need for surgeries or blood transfusions in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • • Children 31 days through 26 years (inclusive) of age who undergo Trauma Red (highest level) activation or Trauma Level 1 (mid-level) activation at Children's Hospital Colorado or Children's National Medical Center.
• Exclusion Criteria:
• • Pregnant patients
• • Incarcerated patients
• • Patients who object to study participation at any time
• • Limited access to or compromised monitoring sites for non-invasive finger sensors
• • Brain death (GCS 3 with fixed, dilated pupils)